We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
1026
Supernus Pharmaceuticals
SUPN
$2.68B
$11K ﹤0.01%
332
PTLA
1027
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11K ﹤0.01%
422
ANAB icon
1028
AnaptysBio
ANAB
$1.6B
$10K ﹤0.01%
172
APLS
1029
DELISTED
Apellis Pharmaceuticals
APLS
$10K ﹤0.01%
398
+40
+11% +$814
CHRS icon
1030
Coherus Oncology
CHRS
$217M
$10K ﹤0.01%
440
ENTA icon
1031
Enanta Pharmaceuticals
ENTA
$372M
$10K ﹤0.01%
124
BOLD
1032
DELISTED
Audentes Therapeutics, Inc
BOLD
$10K ﹤0.01%
271
INVA icon
1033
Innoviva
INVA
$1.58B
$9K ﹤0.01%
597
OPK icon
1034
Opko Health
OPK
$921M
$9K ﹤0.01%
3,729
AERI
1035
DELISTED
Aerie Pharmaceuticals
AERI
$9K ﹤0.01%
289
DBC icon
1036
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$8K ﹤0.01%
500
EDIT icon
1037
Editas Medicine
EDIT
$399M
$8K ﹤0.01%
304
ESPR
1038
DELISTED
Esperion Therapeutics
ESPR
$8K ﹤0.01%
171
FATE icon
1039
Fate Therapeutics
FATE
$281M
$8K ﹤0.01%
410
LKFT
1040
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$8K ﹤0.01%
60
SGMO
1041
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$8K ﹤0.01%
726
+77
+12% +$819
VCYT icon
1042
Veracyte
VCYT
$4.52B
$8K ﹤0.01%
297
+36
+14% +$899
RUBY
1043
DELISTED
Rubius Therapeutics, Inc
RUBY
$8K ﹤0.01%
503
ATNX
1044
DELISTED
Athenex, Inc. Common Stock
ATNX
$8K ﹤0.01%
21
AIMT
1045
DELISTED
Aimmune Therapeutics
AIMT
$8K ﹤0.01%
395
MNTA
1046
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8K ﹤0.01%
626
RARX
1047
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$8K ﹤0.01%
267
ARQL
1048
DELISTED
Arqule Inc
ARQL
$8K ﹤0.01%
712
GTHX
1049
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$7K ﹤0.01%
238
RDUS
1050
DELISTED
Radius Health, Inc.
RDUS
$7K ﹤0.01%
290
+44
+18% +$962

Similar funds

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.